Annual Current Ratio
1.64
-0.90-35.43%
31 December 2023
Summary:
Xeris Biopharma Holdings annual current ratio is currently 1.64, with the most recent change of -0.90 (-35.43%) on 31 December 2023. During the last 3 years, it has fallen by -3.76 (-69.63%). XERS annual current ratio is now -87.51% below its all-time high of 13.13, reached on 31 December 2016.XERS Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
1.79
-0.47-20.80%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly current ratio is currently 1.79, with the most recent change of -0.47 (-20.80%) on 30 September 2024. Over the past year, it has dropped by -0.03 (-1.65%). XERS quarterly current ratio is now -89.17% below its all-time high of 16.53, reached on 30 September 2018.XERS Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.4% | -1.6% |
| 3 y3 years | -69.6% | -46.4% |
| 5 y5 years | -85.8% | -70.0% |
XERS Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -69.6% | at low | -46.4% | +9.2% |
| 5 y | 5 years | -85.8% | at low | -73.9% | +9.2% |
| alltime | all time | -87.5% | at low | -89.2% | +9.2% |
Xeris Biopharma Holdings Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 1.79(-20.8%) |
| June 2024 | - | 2.26(-4.6%) |
| Mar 2024 | - | 2.37(+44.5%) |
| Dec 2023 | 1.64(-35.4%) | 1.64(-9.9%) |
| Sept 2023 | - | 1.82(-6.7%) |
| June 2023 | - | 1.95(-3.9%) |
| Mar 2023 | - | 2.03(-20.1%) |
| Dec 2022 | 2.54(+41.1%) | 2.54(+17.1%) |
| Sept 2022 | - | 2.17(-13.2%) |
| June 2022 | - | 2.50(-6.4%) |
| Mar 2022 | - | 2.67(+48.3%) |
| Dec 2021 | 1.80 | 1.80(-46.1%) |
| Sept 2021 | - | 3.34(-18.1%) |
| June 2021 | - | 4.08(-30.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | 5.86(+8.5%) |
| Dec 2020 | 5.40(+68.8%) | 5.40(-10.6%) |
| Sept 2020 | - | 6.04(-12.0%) |
| June 2020 | - | 6.86(+42.3%) |
| Mar 2020 | - | 4.82(+50.6%) |
| Dec 2019 | 3.20(-72.4%) | 3.20(-46.3%) |
| Sept 2019 | - | 5.96(-0.7%) |
| June 2019 | - | 6.00(-47.6%) |
| Mar 2019 | - | 11.45(-1.2%) |
| Dec 2018 | 11.59(+27.9%) | 11.59(-29.9%) |
| Sept 2018 | - | 16.53(+10.9%) |
| June 2018 | - | 14.91(+129.0%) |
| Mar 2018 | - | 6.51(-28.1%) |
| Dec 2017 | 9.06(-31.0%) | 9.06 |
| Dec 2016 | 13.13 | - |
FAQ
- What is Xeris Biopharma Holdings annual current ratio?
- What is the all time high annual current ratio for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual current ratio year-on-year change?
- What is Xeris Biopharma Holdings quarterly current ratio?
- What is the all time high quarterly current ratio for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly current ratio year-on-year change?
What is Xeris Biopharma Holdings annual current ratio?
The current annual current ratio of XERS is 1.64
What is the all time high annual current ratio for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual current ratio is 13.13
What is Xeris Biopharma Holdings annual current ratio year-on-year change?
Over the past year, XERS annual current ratio has changed by -0.90 (-35.43%)
What is Xeris Biopharma Holdings quarterly current ratio?
The current quarterly current ratio of XERS is 1.79
What is the all time high quarterly current ratio for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly current ratio is 16.53
What is Xeris Biopharma Holdings quarterly current ratio year-on-year change?
Over the past year, XERS quarterly current ratio has changed by -0.03 (-1.65%)